Getting a GRiP on chemoresistance: A review of GRP78 as a therapeutic target in cancer
Innate or acquired resistance to current standard-of-care therapies is a major hindrance to successful chemotherapeutic intervention. There is a critical need to elucidate the underlying mechanisms responsible for chemoresistance ...
Mar 1, 2018
0
3